Related Experiment Video
Updated: Apr 22, 2026
07:39
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
23.4K
[Drug safety: challenge in an aging society]
M Huber1, A Blumberg, S Chatterjee
1Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Kurt-Georg-Kiesinger-Allee 3, 53175, Bonn, Deutschland, martin.huber@bfarm.de.
Der Nervenarzt
|October 9, 2014
Summary
Elderly patients take more medications, increasing drug safety risks. Reporting adverse drug reactions by physicians improves data for safer prescribing in older adults.
Area of Science:
- Geriatric Pharmacology
- Pharmacovigilance
- Public Health
Context:
- Increasing elderly population globally.
- High prevalence of multimorbidity and polypharmacy in older adults.
- Critical need for drug safety in the elderly population.
Purpose:
- To highlight the importance of drug safety in the elderly.
- To emphasize the role of spontaneous reporting in improving drug safety data.
- To introduce the AgeCoDe study for longitudinal drug safety research.
Summary:
- Limited data exists on medication risks for the elderly.
- Spontaneous reporting of adverse drug reactions (ADRs) is crucial for enhancing knowledge.
- Physicians' accurate reporting significantly improves pharmacovigilance effectiveness.
Impact:
- Enhances understanding of drug risks in aging populations.
- Supports regulatory assessments and recommendations for medication use in the elderly.
- Facilitates evidence-based prescribing practices for improved patient outcomes.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
387
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
387
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
354
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
354
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
841
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
841
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
371
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
371
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
379
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
379
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
348
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
348